This finding contrasts with another study analyzing germline BRCA1/2-mutated breast cancer tumors [17]; a greater proportion of patients in this study had one or more BRCA1 mutation with LOH (69.0%) than patients with one or more BRCA2 mutation with LOH (21.4%). This evidence concerns the gene BRCA1 and breast carcinoma.